Gulf Scientific Corporation (GSC), a prominent provider of laboratory solutions, has signed an agreement with R-Biopharm, a leading German biotechnology firm to deliver analytical solutions in Saudi Arabia.
This partnership, marks a significant step in expanding GSC’s portfolio in the fields of health, and quality of life through advanced biotechnological analysis.
R-Biopharm, known for its dedication to consumer and patient health, aligns perfectly with GSC's ethos. This collaboration aims to bring these high-value solutions to Saudi Arabia.
Cutting-edge laboratory solutions
With a robust presence in major cities across the Gulf region, GSC, along with its subsidiaries: Sama Masa, Dar Al-Aalmiyah, ATP Kuwait, JSC, and Atrium, continues to provide cutting-edge laboratory solutions. This new venture with R-Biopharm will further bolster GSC's position as a leader in analytical and material sciences within the GCC.
Manaf Afyouni, Managing Director at GSC, commented: “This partnership will enable us to offer comprehensive analytical solutions through Sama Masa, and Dar Al-Aalmiyah in Saudi Arabia, enhancing our portfolio and furthering our goal to contribute significantly to the scientific advancement and quality of life.”--TradeArabia News Service
&uuid=(email))